NCT02151071View on ClinicalTrials.gov

The Breast Surgery EnLight and LightPath Imaging System Study

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2017

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2019

Conditions
Breast Neoplasms
Interventions
DEVICE

EnLight

The Lightpoint EnLight beta particle detector is an investigational non CE-marked medical device

DEVICE

LightPath

The LightPath Imaging System is an investigational non CE-marked in vitro diagnostic device

Trial Locations (1)

SE1 9RT

Guy's Hospital, London

Sponsors
All Listed Sponsors
collaborator

Guy's and St Thomas' NHS Foundation Trust

OTHER

collaborator

King's College London

OTHER

lead

Lightpoint Medical Limited

INDUSTRY